Poly Medicure Limited Grants 17,500 Stock Options Under ESOP Scheme 2020
Poly Medicure Limited announced the granting of 17,500 stock options to its employees, authorized by the company's Nomination and Remuneration Committee. The options are issued under the existing Employees Stock Option Scheme 2020.The Nomination and Remuneration Committee held its meeting on May 23, 2026, approving the grant.
The details of the options granted are as follows:
| Particulars | Details |
|---|---|
| Options Granted | 17,500 Options |
| Scheme Name | Employees Stock Option Scheme 2020 |
| Shares Covered | 17,500 Equity Shares (1 Option = 1 Share) |
| Grant Price | INR 100/- (discounted price) |
According to the scheme details, the grant price of INR 100/- was set based on applicable provisions and constituted a discounted price relative to the latest closing price prevailing on the Stock Exchange.
Terms of the Scheme
The Employee Stock Option Scheme is administered by the company's Nomination and Remuneration Committee. The options grant 17,500 Equity Shares to employees based on eligibility criteria outlined in the Scheme.Upon vesting, the granted options entitle the option holder to acquire an equal number of Equity Shares upon payment of the exercise price and applicable taxes, according to the terms and conditions of the Scheme.
The scheme outlines specific timelines for exercising the options:
- Exercise Period: The exercise period shall not exceed three months from the relevant Vesting date.
- Vesting Timeline: The options shall not Vest for a period of one year from the date of Grant. Upon the expiry of one year, the vesting of options shall take place over a maximum term of four years as per the Scheme.
POLYMED Stock Price Movement
On Friday, Poly Medicure Limited shares edged higher, gaining 3.19% to close at ₹1598.2. The stock traded on a volume of 120,612 shares, closing near its day's high of ₹1606.2.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.